author-photo

M. Tubiana-Hulin

European Organisation for Research and Treatment of Cancer

16

Papers

1192

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Impact of symptoms and toxicity on quality of life: Exploratory analysis of gemcitabine plus docetaxel vs capecitabine plus docetaxel in metastatic breast cancer

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
Clinical validation of in vitro drug sensitivity microarray data: Regimen-specific signatures predict pathological complete response to neo-adjuvant chemotherapy for breast cancer in a randomized trial (EORTC 10994/BIG 00–01)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902

2009 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (67)
Breast Cancer With Synchronous Metastases: Survival Impact of Exclusive Locoregional Radiotherapy

2009 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (133)
Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy

2008 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (62)
Breast cancer with synchronous metastases: Impact of locoregional radiotherapy (LRR) on survival

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
5BA Clinical validation of in vitro drug sensitivity microarray data: regimen-specific signatures predict pathological complete response to neo-adjuvant chemotherapy for breast cancer in a randomized trial (EORTC 10994/BIG 00-01)

2007 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (0)
O-49 A phase III trial of Gemcitabine plus Docetaxel (GD) versus Capecitabine plus Docetaxel (CD) for patients (pt) with anthracycline-pretreated metastatic breast cancer

2007 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (2)
After 10 years of follow-up, preoperative chemotherapy is still safe in operable breast cancer: Clinical and translational results from the European Organisation for Research and Treatment of Cancer Trial 10902

2006 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (3)
Multicenter, non-randomized phase II study with RPR109881 in taxane-exposed metastatic breast cancer (MBC) patients (pts): Final results

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (13)